DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Bertilimumab
Bertilimumab
Fig. L COMPOSITIONS and METHODS to INHIBIT STEM CELL and PROGENITOR CELL BINDING to LYMPHOID TISSUE and for REGENERATING GERMINAL CENTERS in LYMPHATIC TISSUES
Modifications to the Harmonized Tariff Schedule of the United States To
Monoclonal Antibody Therapy for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease with Eosinophilic Inflammation
(12) Patent Application Publication (10) Pub. No.: US 2017/0172932 A1 Peyman (43) Pub
Novel Therapies for Eosinophilic Disorders
I Regulations
(INN) for Biological and Biotechnological Substances
Ico Therapeutics by STEPHEN DAILY, NEWS EDITOR
Small-Cap Research
[email protected]
INN Working Document 05.179 Update 2011
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
Therapeutic Interventions in Severe Asthma Giorgio Walter Canonica1*, Gianenrico Senna2, Patrick D
Customs Tariff - Schedule
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
(INN) for Biological and Biotechnological Substances
WO 2018/067987 Al 12 April 2018 (12.04.2018) W !P O PCT
On the Anti-Cancer Campaign
(12) United States Patent (10) Patent No.: US 9,446,134 B2 Maggio (45) Date of Patent: *Sep
Top View
Small-Cap Research 312-265-9421
[email protected]
Who Expert Committee on Specifications for Pharmaceutical Preparations
A Few Tricks up Its Sleeve
International Nonproprietary Names for Biological and Biotechnological Substances: a Review17
Wo 2010/095940 A2
Small-Cap Research 312-265-9421 /
[email protected]
Inflammatory Bowel Disease: Exploring Gut Pathophysiology for Novel Therapeutic Targets
Pharmaabkommen A1 E
WO 2016/128558 Al 18 August 2016 (18.08.2016) P O P C T
New Clinical Data Support Bertilimumab Activity in Bullous Pemphigoid
Ico Initiation
Therapeutic Targeting of Chemokines with Monoclonal Antibodies Katrien L
Annexes to the Annual Report of the European Medicines Agency 2018
A Pilot Phase 2A Study of the Safety and Efficacy of Bertilimumab, an Anti-Eotaxin-1 Antibody, in Bullous Pemphigoid
Immunomodulatory Treatment for the Intractable Paediatric Epilepsies Luis E
(12) Patent Application Publication (10) Pub. No.: US 2015/0010548 A1 Jesek Et Al
(INN) for Biological and Biotechnological Substances
Immune Pharmaceuticals Expands Its Bertilimumab Phase II Clinical Trial
Thalidomide - Wikipedia, the Free Encyclopedia
Diverse Threads in IBD Clinical Development
Assessment of the Evolution of Cancer Treatment Therapies
2016 Medicines in Development for Autoimmune Diseases
International Nonproprietary Names (INN) for Biological and Biotechnological Substances
Dexamethasone to Reduce Stem Cell Accumulation in the Spleen
(12) 按照专利合作条约所公布的国际申请w O 2016/050208
Targeting Cell Signaling in Allergic Asthma